A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and […]
Updated Date: Mon, 19 May 2025 00:00:00 EDT
First non-immunosuppressive dual-action therapy approved for eligible patients
Company secures regulatory approvals for commercial rollout in UK and US
Updated Date: Mon, 19 May 2025 00:00:00 EDT
Some patients with a rare form of ALS benefited from an experimental therapy, with biomarker evidence of reduced […]
Worldwide, more than 55 million people suffer from dementia caused by Alzheimer’s Disease (AD) and other conditions that […]
Drug shortagesTwo years ago colleagues and I published two papers detailing various aspects of drug shortages.12 We covered […]
The phrase “imitation is the sincerest form of flattery” is often attributed, probably incorrectly, to Oscar Wilde (it […]
